Indian journal of ophthalmology
-
Indian J Ophthalmol · Sep 1997
Randomized Controlled Trial Comparative Study Clinical TrialTopical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
The efficacy of topical ketorolac 0.5% in treatment of vernal keratoconjunctivitis (VKC) was evaluated in a randomised double-blind prospective trial in 21 patients. Ketorolac treated eyes showed 50.7% reduction in main symptoms of itching compared to 33.3% relief in placebo treated eyes after 2 weeks of treatment (p < 0.01). ⋯ Transient stinging sensation was observed in 3 (14.3%) patients on ketorolac therapy. This study shows efficacy of ketorolac 0.5% solution in controlling symptoms in VKC.